BOTHELL, Wash., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of ...
The success or failure of the development of a biopharmaceutical product is governed by protein stability. Protein stability is considered a critical parameter during manufacturing, production, ...
The ability of SPR-based analysis to estimate association and dissociation rate constants is a major advantage over the traditional steady-state analysis of biomolecules. Biotherapeutics are an ...
As the US biopharmaceutical industry and regulators debate new requirements for biosimilars, industry leaders are turning to analytical science to define intellectual property and business development ...
Formulation is arguably the most critical—and challenging—component of biopharmaceutical drug development, second only to the molecule itself. Formulation’s far-reaching consequences help sponsors ...
A new collaborative study from RedshiftBio (Burlington, MA) and a Major Pharmaceutical Company published in the Journal of Pharmaceutical Sciences provides compelling evidence of the benefits of the ...
AUBAGNE, France--(BUSINESS WIRE)--Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback